Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIRTOBRUTINIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where PIRTOBRUTINIB was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for PIRTOBRUTINIB

Side Effect Reports % Deaths Hosp.
Death 65 14.9% 58 4
Malignant neoplasm progression 43 9.8% 33 23
Disease progression 41 9.4% 9 10
Pneumonia 41 9.4% 26 33
Anaemia 27 6.2% 9 13
Chronic lymphocytic leukaemia 25 5.7% 8 8
Pancytopenia 22 5.0% 1 1
Off label use 21 4.8% 2 4
Drug ineffective 20 4.6% 4 6
White blood cell count increased 19 4.4% 3 6
Covid-19 18 4.1% 11 15
Cytokine release syndrome 17 3.9% 0 0
Platelet count decreased 16 3.7% 11 12
General physical health deterioration 15 3.4% 12 11
Haemoglobin decreased 14 3.2% 8 11

Other Indications for PIRTOBRUTINIB

Chronic lymphocytic leukaemia (133) Mantle cell lymphoma (111) Product used for unknown indication (84) Richter's syndrome (24) Mantle cell lymphoma recurrent (9) B-cell small lymphocytic lymphoma (8) Mantle cell lymphoma refractory (6) Waldenstrom's macroglobulinaemia (6)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

PIRTOBRUTINIB Full Profile All Diffuse large b-cell lymphoma Drugs PIRTOBRUTINIB Demographics PIRTOBRUTINIB Timeline